Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A. Martz, Kris C. Wood, Kathleen Ottina et al.|Science Signaling|2014Cited by 199
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumorsGrace R. Anderson, Kris C. Wood, Alexander P. Yllanes et al.|Nature Communications|2018Cited by 138
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R. Anderson, Kris C. Wood, Peter Winter et al.|Cell Reports|2017Cited by 86
<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGrace R. Anderson, Kris C. Wood, Suzanne E. Wardell et al.|Science Translational Medicine|2016Cited by 58
Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspiratesDaniel Y. Joh, Ashutosh Chilkoti, Jacob T. Heggestad et al.|npj Breast Cancer|2021Cited by 17